AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD
The German pharmaceutical company Altana AG has received approval from the US Food and Drug Administration to market an intravenous (IV) form of its Protonix gastrointestinal drug in the US.
The IV version, which is already available in 43 countries worldwide, is meant for patients who are unable to take Protonix - known as Pantoprazole in the US - in tablet form. According to Altana the approval makes Protonix/Pantoprazole the first …